Increased Incidence of Thyrotoxicosis After Iodine Supplementation in an Iodine Sufficient Area

Overview

Journal J Endocrinol Invest

Publisher Springer

Specialty Endocrinology

Date 1994 Jan 1

PMID 8006325

Citations 9

Authors

J C Galofre

M Rios

R V Garcia-Mayor

Affiliations

Soon will be listed here.

Abstract

Unlabelled: The aim of this study was to determine the incidence rate of thyrotoxicosis (TT) before and during dietary-iodine supplementation in an iodine-sufficient area.

Population: the study was carried out in Vigo, South Galicia (northwest of Spain), from January 1977 to December 1989. The mean population throughout the study period was 267,330 inhabitants (47% males and 53% females). From January 1985, a mandatory consumption of iodinized salt on the whole population started in Galicia. This region was considered as an iodine-deficient area but Vigo is an iodine-sufficient area.

Measurements: all newly diagnosed TT cases in Vigo city within the study period were included in this study. Diagnosis of TT was based on the clinical manifestations, an elevated level of T4 and suppressed TSH values. The difference between diffuse and nodular forms of goiter was assessed by scintigraphy. The average incidence rate (AIR) was determined in two periods, before (period A, 1977-1984) and during (period B, 1985-1989) iodine supplementation.

Results: the AIR throughout the whole study period was 4.89 new cases per 100,000 population, 95% confidence limits 4.16 to 5.63; AIR was 1.34 for males and 8.03 for females. AIR in period B was significantly higher with respect to period A, 7.68 and 3.10 per 100,000 respectively. The confidence interval for the difference was from -20.4 to 30.1, p < 0.05. The increase of the incidence of TT was comprised of both nodular and diffuse goiters.

Conclusions: dietary iodinesupplementation in iodine-sufficient areas may induce an increase of the incidence of TT.(ABSTRACT TRUNCATED AT 250 WORDS)

Citing Articles

Relationship Between Thyroid Hormonal Status in Patients with a Hypothyroid Form of Hashimoto's Thyroiditis and Iodine Concentrations in Drinking Water.

Kasiyan O, Tkachenko H, Kurhaluk N, Yurchenko S, Manenko A Biol Trace Elem Res. 2021; 200(1):59-66.

PMID: 33650064 PMC: 8585830. DOI: 10.1007/s12011-021-02640-2.

Graves' disease.

Davies T, Andersen S, Latif R, Nagayama Y, Barbesino G, Brito M Nat Rev Dis Primers. 2020; 6(1):52.

PMID: 32616746 DOI: 10.1038/s41572-020-0184-y.

Urinary Iodine Concentration and Mortality Among U.S. Adults.

Inoue K, Leung A, Sugiyama T, Tsujimoto T, Makita N, Nangaku M Thyroid. 2018; 28(7):913-920.

PMID: 29882490 PMC: 6916127. DOI: 10.1089/thy.2018.0034.

Global epidemiology of hyperthyroidism and hypothyroidism.

Taylor P, Albrecht D, Scholz A, Gutierrez-Buey G, Lazarus J, Dayan C Nat Rev Endocrinol. 2018; 14(5):301-316.

PMID: 29569622 DOI: 10.1038/nrendo.2018.18.

Consequences of excess iodine.

Leung A, Braverman L Nat Rev Endocrinol. 2013; 10(3):136-42.

PMID: 24342882 PMC: 3976240. DOI: 10.1038/nrendo.2013.251.

References

Safran M, Paul T, Roti E, Braverman L . Environmental factors affecting autoimmune thyroid disease. Endocrinol Metab Clin North Am. 1987; 16(2):327-42. View

Brownlie B, Wells J . The epidemiology of thyrotoxicosis in New Zealand: incidence and geographical distribution in north Canterbury, 1983-1985. Clin Endocrinol (Oxf). 1990; 33(2):249-59. DOI: 10.1111/j.1365-2265.1990.tb00489.x. View

van Leeuwen E . [A form of genuine hyperthyroidism (Basedow's disease without exophthalmos) following ingestion of iodized bread]. Ned Tijdschr Geneeskd. 1954; 98(2):81-9. View

Garcia R, Gomez Sobreira M, Batista J, MOREIRAS M, Lazaro Enguis J, Alvarez Gandara D . [Thyroid clinical dysfunction in patients chronically treated with amiodarone]. Rev Esp Cardiol. 1990; 43(4):227-30. View

Fradkin J, Wolff J . Iodide-induced thyrotoxicosis. Medicine (Baltimore). 1983; 62(1):1-20. DOI: 10.1097/00005792-198301000-00001. View

Haraldsson A, Gudmundsson S, Larusson G, Sigurdsson G . Thyrotoxicosis in Iceland 1980-1982. An epidemiological survey. Acta Med Scand. 1985; 217(3):253-8. DOI: 10.1111/j.0954-6820.1985.tb02691.x. View

Thommesen N, Nirell I, KRISTENSEN H . [Material on hyperthyroidism from a five-year period in a central hospital]. Ugeskr Laeger. 1971; 133(34):1663-9. View

Solomon B, Evaul J, Burman K, Wartofsky L . Remission rates with antithyroid drug therapy: continuing influence of iodine intake?. Ann Intern Med. 1987; 107(4):510-2. DOI: 10.7326/0003-4819-107-4-510. View

MOGENSEN E, Green A . The epidemiology of thyrotoxicosis in Denmark. Incidence and geographical variation in the Funen region 1972-1974. Acta Med Scand. 1980; 208(3):183-6. View

10.

Williams I, Ankrett V, Lazarus J, Volpe R . Aetiology of hyperthyroidism in Canada and Wales. J Epidemiol Community Health. 1983; 37(3):245-8. PMC: 1052301. DOI: 10.1136/jech.37.3.245. View

11.

Garcia-Mayor R, Paramo C, Luna Cano R, Perez Mendez L, Galofre J, Andrade A . Antithyroid drug and Graves' hyperthyroidism. Significance of treatment duration and TRAb determination on lasting remission. J Endocrinol Invest. 1992; 15(11):815-20. DOI: 10.1007/BF03348811. View

12.

Connolly R . The changing age incidence of jodbasedow in Tasmania. Med J Aust. 1973; 2(4):171-4. DOI: 10.5694/j.1326-5377.1973.tb128753.x. View

13.

Martino E, Safran M, Aghini-Lombardi F, Rajatanavin R, Lenziardi M, Fay M . Environmental iodine intake and thyroid dysfunction during chronic amiodarone therapy. Ann Intern Med. 1984; 101(1):28-34. DOI: 10.7326/0003-4819-101-1-28. View

14.

Cohen S, Weetman A . The effect of iodide depletion and supplementation in the Buffalo strain rat. J Endocrinol Invest. 1988; 11(8):625-7. DOI: 10.1007/BF03350197. View

15.

REINWEIN D, Benker G, KONIG M, Pinchera A, Schatz H, Schleusener H . Hyperthyroidism in Europe: clinical and laboratory data of a prospective multicentric survey. J Endocrinol Invest. 1986; 9 Suppl 2:1-36. View

16.

Adams D, KENNEDY T, Stewart J, UTIGER R, VIDOR G . Hyperthyroidism in Tasmania following iodide supplementation: measurements of thyroid-stimulating autoantibodies and thyrotropin. J Clin Endocrinol Metab. 1975; 41(2):221-8. DOI: 10.1210/jcem-41-2-221. View

17.

Kicic M . [Problems of hyperthyreosis during the introduction of endemic thyreopathic dystrophy prevention using iodine]. Vojnosanit Pregl. 1977; 34(6):409-21. View

18.

Furszyfer J, Kurland L, McConahey W, ELVEBACK L . Graves' disease in Olmsted County, Minnesota, 1935 through 1967. Mayo Clin Proc. 1970; 45(9):636-44. View

19.

Allen E, Appel M, Braverman L . The effect of iodide ingestion on the development of spontaneous lymphocytic thyroiditis in the diabetes-prone BB/W rat. Endocrinology. 1986; 118(5):1977-81. DOI: 10.1210/endo-118-5-1977. View

20.

Barker D, Phillips D . Current incidence of thyrotoxicosis and past prevalence of goitre in 12 British towns. Lancet. 1984; 2(8402):567-70. DOI: 10.1016/s0140-6736(84)90776-1. View